Tourmaline Bio, Inc. - Common stock, par value $0.0001 per share (TRML)

106 filings reported holding TRML - Tourmaline Bio, Inc. - Common stock, par value $0.0001 per share as of Q3 2024.
Tourmaline Bio, Inc. - Common stock, par value $0.0001 per share (TRML) has 90 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 21,032,430 shares of 25,669,673 outstanding shares and own 82% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (2,538,925 shares), Avoro Capital Advisors LLC (2,222,222 shares), BlackRock, Inc. (1,753,347 shares), Blue Owl Capital Holdings LP (1,530,401 shares), TCG Crossover Management, LLC (1,477,593 shares), JENNISON ASSOCIATES LLC (1,151,973 shares), VANGUARD GROUP INC (1,062,473 shares), Qiming U.S. Ventures Management, LLC (741,691 shares), RTW INVESTMENTS, LP (741,656 shares), and QVT Financial LP (711,275 shares).
This table shows the top 90 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.